Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 897517 | ISIN: IL0010826357 | Ticker-Symbol: NUR
Frankfurt
27.06.25 | 15:29
13,800 Euro
-3,50 % -0,500
1-Jahres-Chart
ELLOMAY CAPITAL LTD Chart 1 Jahr
5-Tage-Chart
ELLOMAY CAPITAL LTD 5-Tage-Chart
RealtimeGeldBriefZeit
13,30015,70013:03

Aktuelle News zur ELLOMAY CAPITAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.06.Ellomay Capital Ltd: Ellomay Capital Announces the Closing of the Investment by Clal Insurance in Ellomay Capital's 198 MW Italian Solar Portfolio1
20.06.Ellomay Capital Ltd. - 6-K, Report of foreign issuer2
30.05.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
30.05.Ellomay Capital Ltd: Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. as of and for the Three Months Ended March 31, 202594TEL-AVIV, Israel, May 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
ELLOMAY CAPITAL Aktie jetzt für 0€ handeln
30.04.Ellomay Capital Ltd. - 6-K, Report of foreign issuer1
09.04.Ellomay Capital enters into investment agreement with Clal Insurance2
09.04.Ellomay Capital Ltd. Announces the Execution of an Agreement to sell 49% of its Italian Solar Portfolio of 198 MW to Clal Insurance, a Leading Israeli Institutional Investor103Tel-Aviv, Israel, April 09, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
07.04.Ellomay Capital Ltd. - 6-K, Report of foreign issuer2
31.03.Ellomay Capital Ltd: Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2024103TEL-AVIV, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
31.03.Ellomay Capital Ltd: Ellomay Capital Reports Publication of Financial Statements of Dorad Energy Ltd. for the Year Ended December 31, 20241
31.03.Ellomay Capital Ltd. - 6-K, Report of foreign issuer1
04.03.Ellomay Capital secures US$116 million loan for 198MW Italian solar portfolio2
03.03.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
02.03.Ellomay Capital Ltd: Ellomay Capital Announces Execution of Project Finance Agreements for its 198 MW Solar Portfolio in Italy77Tel-Aviv, Israel, March 02, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
18.02.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
10.02.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
30.01.Ellomay Capital Ltd: Ellomay Capital Announces Results of Extraordinary General Meeting of Shareholders135Tel-Aviv, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
30.01.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
21.01.Ellomay Capital Ltd. - 6-K, Report of foreign issuer-
30.12.24Ellomay Capital Ltd: Ellomay Capital Reports Results for the Three and Nine Months Ended September 30, 2024175TEL-AVIV, Israel, Dec. 30, 2024 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable...
► Artikel lesen
Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1